Multimodality Radiological Pictorial Review of Testicular Carcinoma: From Initial Staging to Restaging.
Jonathan Wesley RevelsSherry S WangKiran GangadharArafat AliAl-Amin AliJean H LeePublished in: Research and reports in urology (2020)
With an overall 5-year survival rate >95%, patients with testicular cancer have a great prognosis. Although initial diagnosis is based on clinical examination, imaging does play a significant role in the diagnosis and prognosis of testicular cancer, which are dependent on tumor burden and staging. Successful treatment requires appropriate disease assessment throughout a patient's treatment: evaluating treatment response, restaging, and monitoring for disease recurrence after treatment completion. Ultrasound is usually the initial screening modality for painless testicular masses, and computedtomography (CT) the most commonly used for staging and restaging. However, with regard to seminomas, positron-emission tomography (PET) combined with CT is slowly taking priority. With regard to nonseminomatous germ-cell tumors, PET-CT has not proven to be completely effective, due to a high number of false-negative results. The purpose of this paper is to provide radiologists with a pictorial review of testicular carcinoma from initial staging through posttreatment follow-up.
Keyphrases
- germ cell
- pet ct
- positron emission tomography
- computed tomography
- papillary thyroid
- pet imaging
- lymph node
- contrast enhanced
- squamous cell
- magnetic resonance imaging
- high resolution
- image quality
- dual energy
- ultrasound guided
- machine learning
- artificial intelligence
- lymph node metastasis
- squamous cell carcinoma
- free survival
- risk factors
- magnetic resonance